Evidence map›Paper›PMID 35409465›Full record

ArticleInternational journal of environmental research and public health2022

Lawrence Mabasa, Anri Kotze, Samukelisiwe Shabalala, Clare Kimani, Kwazi Gabuza, Rabia Johnson, Nonhlakanipho F Sangweni, Vinesh Maharaj, Christo J F Muller

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Potential Impact ofAntioxidants (Basel, Switzerland) · 2025
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Lawrence MabasaBiomedical Research and Innovation Platform (BRIP), South African Medical Research Council (SAMRC), Tygerberg 7505, South Africa.ORCID 0000-0001-6499-3396
Anri KotzeBiomedical Research and Innovation Platform (BRIP), South African Medical Research Council (SAMRC), Tygerberg 7505, South Africa.
Samukelisiwe ShabalalaBiomedical Research and Innovation Platform (BRIP), South African Medical Research Council (SAMRC), Tygerberg 7505, South Africa.ORCID 0000-0003-1238-4673
Clare KimaniBiomedical Research and Innovation Platform (BRIP), South African Medical Research Council (SAMRC), Tygerberg 7505, South Africa.
Kwazi GabuzaBiomedical Research and Innovation Platform (BRIP), South African Medical Research Council (SAMRC), Tygerberg 7505, South Africa.ORCID 0000-0003-0144-6664
Rabia JohnsonBiomedical Research and Innovation Platform (BRIP), South African Medical Research Council (SAMRC), Tygerberg 7505, South Africa.ORCID 0000-0002-6328-0789
Nonhlakanipho F SangweniBiomedical Research and Innovation Platform (BRIP), South African Medical Research Council (SAMRC), Tygerberg 7505, South Africa.
Vinesh MaharajDepartment of Chemistry, University of Pretoria, Pretoria 0001, South Africa.ORCID 0000-0002-6512-304X
Christo J F MullerBiomedical Research and Innovation Platform (BRIP), South African Medical Research Council (SAMRC), Tygerberg 7505, South Africa.ORCID 0000-0001-6821-2120
South African Medical Research Council · ZAUniversity of Pretoria · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a spectrum of hepatic metabolic perturbations ranging from simple steatosis to steatohepatitis, cirrhosis and hepatocellular carcinoma. Currently, lifestyle modifications to reduce weight gain are considered the most effective means of preventing and treating the disease. The aim of the present study was to determine the therapeutic benefit of

Indexed as

AnacardiaceaeLiver NeoplasmsNon-alcoholic Fatty Liver DiseaseAnimalsLipid MetabolismLiverMiceMice, Inbred C57BLMice, ObeseObesityPlant ExtractsRNA, MessengerPlant ExtractsRNA, MessengerDNA methylationMarula leaf extractmethylenetetrahydrofolate reductasenon-alcoholic fatty liver diseaseβ-oxidation

Identifiers

PMID35409465
PMCPMC8998011
OpenAlexW4221105402

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.